Patent details

Basic Information

Publication number:

EP2976096

PCT Application Number:

EP2014055533

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147130728

PCT Publication Number:

WO2014147141

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

INSULIN DOSING REGIMEN

French Title of Invention:

RÉGIME DE DOSAGE POUR INSULINE

German Title of Invention:

INSULINDOSIERSCHEMA

SPC Number:

Dates

Filing date:

19/03/2014

Grant date:

27/02/2019

EP Publication Date:

27/01/2016

PCT Publication Date:

25/09/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/02/2019

EP B1 Publication Date:

27/02/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

19/03/2019

Expiration date:

19/03/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/02/2019

 

 

Name:

Novo Nordisk A/S

Address:

Novo Allé, 2880 Bagsværd, Denmark (DK)

Inventor

Name:

JOHANSEN, Thue

Address:

Denmark (DK)

Priority

1

Priority Number:

13160194

Priority Date:

20/03/2013

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

201361804363 P

Priority Date:

22/03/2013

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00; A61K 38/28;

Publication

European Patent Bulletin

Issue number:

201909

Publication date:

27/02/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages